CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Clinical trial NCT05774899 · RECRUITING
Trial details
- NCT number
- NCT05774899
- Sponsor
- Glenn J. Hanna
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.